EMX Capital acquires a mayority stake in a pharmaceutical company

25 July, 2014

EMX Capital acquired a majority stake in Farmapiel, a Mexican company founded in 1990 aiming to take a leadership position in the pharmaceutical dermatological industry. Farmapiel holds a solid position to serve dermatologists, plastic surgeons, healthcare professionals and their patients with dermatological products of the highest quality and with the best professional standards in industry.

Currently, The Company has a line of products that consists of 12 brands across five categories (wound/scar treatment, clarifying agents, anti-ageing products, anti-acne treatment and feminine health).

Back to News